ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

South Korea flag South Korea · Delayed Price · Currency is KRW
953.00
+13.00 (1.38%)
At close: Apr 28, 2026
-10.93%
Market Cap 29.06B
Revenue (ttm) 59.31B
Net Income (ttm) -6.81B
Shares Out 30.98M
EPS (ttm) -220.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 104,806
Average Volume 144,241
Open 940.00
Previous Close 940.00
Day's Range 929.00 - 960.00
52-Week Range 790.00 - 1,420.00
Beta 0.56
RSI 57.99
Earnings Date Mar 20, 2026

About KOSDAQ:034940

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers i... [Read more]

Industry Pharmaceutical Preparations
Founded 1964
Employees 269
Stock Exchange KOSDAQ
Ticker Symbol 034940
Full Company Profile

Financial Performance

In 2025, KOSDAQ:034940's revenue was 59.31 billion, a decrease of -5.40% compared to the previous year's 62.69 billion. Losses were -6.81 billion, -29.14% less than in 2024.

Financial Statements

News

There is no news available yet.